Monday, 8 August, 2022
TopicPharmaceutical industry

Topic: Pharmaceutical industry

Watchdog on pharma ethics violations says it has no such power in RTI reply, takes U-turn later

NPPA has been seeking reports from industry bodies on complaints regarding violations of the self-regulatory mechanism meant to discourage pharma malpractices. But it said in reply to an RTI query that this isn't part of its mandate. 

India could need 33 lakh dexamethasone pills by 15 Aug, govt takes stock with pharma firms

Government has directed manufacturers to ensure adequate production of Covid drugs dexamethasone, methylprednisolone and enoxaparin.

Depending on China for imports could threaten India’s drug security: Export council DG

Udaya Bhaskar, Director-General of Pharmexcil, says India’s over-dependence on China for its bulk drugs requirement led to fall in exports in February and March.

Modi govt’s Rs 7,000-cr scheme to reduce API dependence on China could roll out this month

The criteria for selection of domestic manufacturers for APIs could include 'higher production capacities' and usage of latest technologies that are less polluting.

Why AstraZeneca is pondering a $240 billion gamble with Gilead

Combining the science teams of two pharma giants ought to aid future drug discovery. But it's still not clear if either side needs this deal.

Why India saw only 4 pharma products launched in April, its lowest count ever

The pharma industry has seen a fall of about 99% in new product launches since April 2019, when 349 products were launched.

US drug regulator approves use of diabetes drug, also sold in India, to prevent heart attack

The drug Farxiga is sold in India by UK-based pharma giant AstraZeneca under the brand name ‘Forxiga’ to treat type 2 diabetes.

How India can be a world leader in making Covid vaccine and keeping it cheap too

With a system of mass manufacturing already in place, India is set to play a major role in producing the Covid-19 vaccine and selling it at affordable price across the globe.

Can India balance its domestic pharma needs and also be a global player in Covid-19 fight?

India has lifted the ban on the export of 24 pharmaceutical ingredients, including anti-malaria drug hydroxychloroquine.

India and US must join hands during Covid-19 crisis, not increase nativist impulses

Katherine B. Hadda, former US consul general, Hyderabad, writes on the need for the US and India to unite during the Covid-19 crisis.

On Camera

YourTurn

Police detain Rahul Gandhi during a protest march from Parliament to Rashtrapati Bhawan against ED's interrogation of the party's interim President Sonia Gandhi in the National Herald case in New Delhi, on 26 July 2022 | PTI

Rahul Gandhi embraces his lineage as ‘family of sacrifice’, calls out obsessive Congress-haters

The two fake storylines of corruption and dynasty can now no longer be cloaked in the cruel realities of staggering inequality and charged communal relations. The gloves are off.
A suspension pylon in Tamil Nadu | Commons

You thought power subsidy is a Delhi-Punjab problem? Check out Tamil Nadu’s power sector mess

RBI data shows Indian discoms owe power generation firms over Rs 4.5 lakh crore, almost a third of which is owed by Tamil Nadu, where power subsidy cost is twice that of food subsidy.

Defence

The Flying Dolphin — how a former Indian Navy submariner qualified as a commercial pilot 

Vivek Chaudhary retired from the Indian Navy in 2017 after serving on the  Short-Service Commission. After that, his dreams took flight. 

In Kashmir 3 years on, 3 positive changes, 3 things that should’ve happened & 3 that got worse

Kashmir as a crisis has fallen off our headlines and from the top of our collective minds. Which is precisely the most important change for the better.
×